Loading
Latest filing published 29 Sept 2017 for RavenQuest BioMed Inc..
No signal scores available.
Only one filing by David Allen Cross is known so far (29 September 2017): a transaction, in RavenQuest BioMed Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.